Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2019 | Pegcetacoplan: mechanism of action within the complement system

Bruno Fattizzo • 2 Apr 2019
BSH 2019
Anemias Pegcetacoplan

Pegcetacoplan binds to C3 and blocks the cleavage of C3 into C3a and C3b by C3 convertase. Bruno Fattizzo, MD, of the University of Milan, Milan, Italy, discusses the mechanism of action of this agent within the complement system and how this impacts hemolysis and hemoglobin levels at the British Society for Haematology (BSH) 2019 Annual Meeting, held in Glasgow, UK.

More from Bruno Fattizzo

1:53
Inhibition of C3 with APL-2 in autoimmune hemolytic anemia to reduce hemolysis
Bruno Fattizzo • 2 Apr 2019

Related Videos

3:18
Immune-mediated bone marrow failure diseases & their pathophysiology: aplastic anemia, LR-MDS & PNH
Carlo Dufour • 15 Apr 2024
3:45
A 2-year analysis of the EBMT-SAAWP RACE trial: eltrombopag in aplastic anemia
Antonio Risitano • 16 Apr 2024
1:31
Mitapivat improves work/school attendance in patients with pyruvate kinase deficiency
Hanny Al-Samkari • 9 Dec 2023
2:13
SATISFY: mitapivat in patients with erythrocyte membranopathies
Kevin Kuo • 10 Dec 2023
The content of VJHemOnc is intended for healthcare professionals